Immucell Corporation reported preliminary unaudited sales results for the second quarter, six months and twelve months ended June 30, 2023. For the quarter, the company reported total sales of $3.53 million against $3.86 million a year ago.

For the six months, the company reported total sales of $6.98 million against $9.86 million a year ago.

For the twelve-months, the company reported $15.69 million against $20.46 million a year ago.